SELL at the dated $8.01 quote. Base present value is $1.84, with a conditional $0.50–$4.06 range. Technical progress and real customers still need to become durable cash generation after development, investment and ownership claims.
| Metric | Value |
|---|---|
| Bear | 0.50 |
| Base | 1.84 |
| Bull | 4.06 |
| Scenario | Probability | Present value | vs $8.01 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 30% | $0.50 | −94% | Limited demand, cost cuts and finite wind-down | 2030 revenue $64m; illustrative recovery $0.93/share |
| Base | 50% | $1.84 | −77% | Strong sensing and computing ramp with delayed cash generation | 2038 revenue $1.100bn; $58m gross future funding |
| Bull | 20% | $4.06 | −49% | Faster repeat deployment and stronger access economics | 2038 revenue $2.604bn; $181.7m gross future funding |
| Subjective 30/50/20 weights; not measured probabilities or a guaranteed range. Outcomes beyond these cases remain possible. | |||||
| Signpost | Now (Q3 2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| Annual revenue floor | $45.1m guidance; $32.594m nine months | At least $12.506m Q4 with better economics | Delivery shortfall or unfavorable estimates | Q4 2026 results |
| Contract conversion | $36.1m scheduled 2027 obligations | Profitable recognition and new work | Timing shifts or project losses | 2027 reporting |
| Technical roadmap | 30 logical qubits demonstrated | Useful performance progresses toward 100 | Roadmap or workload limitations | 2028 target |
| Cash availability | $28.3m tax withholding excluded | Remittance and funding needs reconcile | Additional obligations or faster burn | Next current/quarterly filing |
| Controls and ownership | Ineffective controls; award claims disclosed | Documented remediation and clear settlements | Continuing weaknesses or worse funding terms | 2027 remediation/testing window |
Technical milestones and guidance are company statements. Forecasts, financing terms and valuations are author assumptions, with current control weaknesses explicitly retained.
Our call is SELL at the dated $8.01 after-hours observation on November 16, 2026, at 7:59:42 p.m. Eastern. Base present fair value is $1.84 per share, with conditional bear and bull values of $0.50 and $4.06. These are model estimates rather than trading boundaries. An outcome beyond the bull is possible, and a distressed outcome could be worse than the bear. The central issue is how much commercial success the current stock price requires after research, equipment, operating capital and existing ownership claims.
Infleqtion has real technical progress, customer-funded work and substantial financial assets. The demonstration of 30 entangled logical qubits is an important reported step on its roadmap. It does not establish broad commercial computing advantage, recurring customer economics or the cash that will ultimately belong to each common share. The company also sells sensing and related technologies with nearer-term applications. Treating the entire group as either a laboratory with no value or a mature software platform would miss those different commercial timelines.
The main valuation separates modeled sensing and development revenue from computing-system and access revenue. This is our analytical structure; Infleqtion reports one operating segment and does not disclose that exact segment split. The forecasts include a substantial ramp, improving gross margins, research, administration, capital expenditure and operating capital. A financing schedule then checks whether the treasury lasts until cash generation. Existing options, warrants and other claims are allocated conservatively, and new financing receives matching ownership rather than being counted as free value.
Business quality, model risk, present value and expected return remain separate. Technical progress and government demand support the business opportunity. Long development periods, uncertain commercial advantage, contract accounting and unresolved controls create high uncertainty. Subjective 30% bear, 50% base and 20% bull weights produce $1.88 of weighted present value, close to the main base. The required investment return is 18%, distinct from the 16% valuation discount rate. The separate December 2030 base price is $2.34, implying a negative annualized return from the dated quote.
| Metric | Value |
|---|---|
| After-hours quote | 8.01 |
| Base present value | 1.84 |
| Weighted present value | 1.88 |
Third-quarter revenue was $9.149 million, up approximately 25% from $7.311 million. Product revenue was $2.650 million and service revenue was $6.499 million. Total cost of revenue was $10.270 million, producing a GAAP gross loss of $1.121 million. Research and development of $11.486 million and selling, general and administrative expense of $22.031 million, partly offset by grant income, led to a $34.479 million operating loss. Revenue growth therefore coexisted with substantial costs of development and delivery.
The sequential comparison requires the corrected second-quarter filing. Q2 revenue was $13.538 million, with $2.167 million of gross profit and a $29.858 million operating loss. Current Q3 revenue was approximately 32.4% lower than that corrected revenue figure. The company’s record language should not be interpreted as a claim that Q3 exceeded every previous quarter. The year-over-year increase is real, but the quarterly delivery pattern is uneven. Investors should use the filed corrected comparison rather than the earlier preliminary earnings presentation.
In August, the company amended preliminary Q2 results for contract revenue and cost recognition and expected-loss accounting. The amendment also described certain prior comparative changes as immaterial. That history makes the mechanics of long-term contract estimates particularly relevant. It does not justify discarding every reported number, and it does not justify assuming the issue is fully cured. We use the current filed figures, preserve the distinction between preliminary and corrected results, and keep the current control weaknesses visible in the risk assessment.
Nine-month revenue was $32.594 million against $20.783 million, with gross profit of $3.581 million and an operating loss of $97.368 million. Those figures show progress in commercial activity, but also the scale of the resources being committed. The company maintained annual revenue guidance of at least $45.1 million. That implies at least $12.506 million in the fourth quarter, calculated by subtracting nine-month revenue. This is our arithmetic, not a separately issued quarterly range or a promise that the minimum will be exceeded.
| Metric | Value |
|---|---|
| Q3 2025 | 7.31 |
| Corrected Q2 2026 | 13.54 |
| Q3 2026 | 9.15 |
| Metric | Q3 2026 |
|---|---|
| Gross loss | −$1.121m |
| Research and development | $11.486m |
| Selling, general and administrative | $22.031m |
| Grant income | $0.159m |
| Operating loss | −$34.479m |
The company develops neutral-atom technologies for sensing, computing and related software. Sensing applications include precision timing, navigation when conventional positioning is unavailable, radio-frequency detection and gravity measurement. Computing requires customers to derive useful value from increasingly capable systems and workloads. The two paths can share technical foundations and personnel while generating cash on different schedules. The model therefore uses separate commercial drivers without pretending the issuer supplies audited segment profit or product-unit economics for each modeled engine.
The reported revenue categories are products and services, not sensing and computing. Services represented about 71% of Q3 revenue, and 89% of group revenue came from government customers. Approximately $8.306 million of quarterly revenue was recognized over time. Engineering and development contracts can therefore contribute revenue as work progresses, before final acceptance or delivery. That is different from a diversified subscription platform with recurring usage revenue. Contract scope, cost estimates, milestones and customer funding all affect how much economic value the reported sales produce.
The company disclosed a $20 million NASA-related expansion, taking cumulative contract value to $40 million, and a separate $12 million spectrum-system award for engineering and validation. The expansion is not an additional $40 million on top of the $20 million. Nor are those headline awards all current revenue. We do not add them again to remaining performance obligations without a contract-level reconciliation. Their importance is the funded work and customer validation they may support, while the timing and economics of recognition still need to be monitored.
The September filing schedules $10.9 million of non-cancelable remaining performance obligations for the rest of 2026, $36.1 million for 2027 and $4.2 million for 2028. Those amounts provide more tangible visibility than a general market-size claim. They are not the whole future revenue opportunity, and they are not a substitute for understanding costs. The $10.9 million scheduled for the remaining year is below the $12.506 million implied fourth-quarter minimum, so delivering the annual outlook also depends on revenue beyond that specific scheduled amount or changes in timing.
| Commercial evidence | Financial meaning |
|---|---|
| NASA expansion | $20m incremental; $40m cumulative contract |
| Spectrum-system award | $12m engineering and validation |
| Government customers | 89% of Q3 revenue |
| Over-time recognition | $8.306m of $9.149m Q3 revenue |
Infleqtion reports demonstrating 30 entangled logical qubits using 80 physical qubits on its Sqale platform. Its stated roadmap targets 100 logical qubits in 2028. These are technical milestones, not a disclosed revenue or profit formula. Useful commercial computing also depends on reliable operations, workload depth, error management, throughput and customer willingness to pay. We do not infer that a particular logical-qubit count proves broad commercial advantage or that a collaboration with a large technology company guarantees future purchases.
The base forecast begins in 2027 with $50 million of sensing and development revenue. Computing contributes two system-equivalent sales at $6 million each, plus $2 million of access and related software revenue, for $64 million in total. The system count and price are author constructs rather than disclosed orders or realized selling prices. They are used to make the commercial assumptions inspectable. A real business can sell installations, services and access in combinations that do not fit that simplified unit model exactly.
By 2038, the base reaches $400 million of sensing revenue and $700 million of computing revenue. Computing consists of 55 annual system equivalents at $8 million plus $260 million of access revenue. Sensing gross margin rises from 35% to a mature 48%; computing rises from 15% to 64%. Those are substantial improvements from current results and depend on a more repeatable commercial offering. The higher computing margin includes a favorable software and access mix. It is not a claim that every physical quantum system can earn software-like economics.
Research begins at $50 million in 2027 and rises to $160 million in 2038; administration and selling costs rise from $45 million to $150 million. Economic future compensation, royalties and rental costs remain in the relevant cost assumptions. We do not add back stock compensation and then assume future technical staff are free. The mature base produces $330 million of operating profit in 2038, but the intervening cash demands are large. The value of those distant earnings depends on the time and capital required to reach them.
| Year | Sensing / development | Systems | System ASP | Access | Total revenue |
|---|---|---|---|---|---|
| 2027 | $50.0m | 2 | $6.0m | $2.0m | $64.0m |
| 2028 | $65.0m | 3 | $6.0m | $4.0m | $87.0m |
| 2029 | $85.0m | 4 | $6.5m | $8.0m | $119.0m |
| 2030 | $110.0m | 6 | $7.0m | $15.0m | $167.0m |
| 2031 | $140.0m | 9 | $7.5m | $25.0m | $232.5m |
| 2032 | $175.0m | 13 | $8.0m | $40.0m | $319.0m |
| 2033 | $215.0m | 18 | $8.0m | $65.0m | $424.0m |
| 2034 | $255.0m | 24 | $8.0m | $95.0m | $542.0m |
| 2035 | $295.0m | 31 | $8.0m | $130.0m | $673.0m |
| 2036 | $335.0m | 39 | $8.0m | $170.0m | $817.0m |
| 2037 | $370.0m | 47 | $8.0m | $215.0m | $961.0m |
| 2038 | $400.0m | 55 | $8.0m | $260.0m | $1100.0m |
The GAAP gross loss includes $2.166 million of stock compensation in cost of revenue. Excluding that item produces $1.045 million of adjusted gross profit. This distinction helps explain why the GAAP margin does not measure only cash production costs. It does not establish that compensation has no economic cost. Total quarterly stock compensation was $10.937 million, and the nine-month amount was $31.296 million. The valuation handles existing claims separately from future economic pay rather than treating all stock-based expense as either worthless accounting noise or an automatic second cash deduction.
The quarterly net loss of $19.679 million was much smaller than the operating loss partly because of $5.289 million of interest income and a $9.742 million unrealized gain on a private investment. The investment gain followed an observable financing transaction and increased the carrying value of a $3 million investment to $12.742 million. It is not quantum-product revenue and did not generate operating cash during the quarter. We treat the holding as a separate non-operating asset and do not capitalize the gain as recurring earnings.
Current disclosure controls remain ineffective. The filing identifies weaknesses involving accounting staffing, segregation of duties, monitoring, equity records and information-technology controls. Remediation and testing may extend into 2027. Filing a current 10-Q does not establish that those weaknesses have been fixed. The prior revenue and expected-loss corrections reinforce the need to inspect contract estimates and cost recognition. Our use of reported figures is accompanied by that limitation; it is not an assertion of clean controls or complete precision.
For contracts subject to expected-loss accounting, an estimate that total costs exceed expected consideration can require recognizing the loss when it becomes evident. Changes in expected revenue and cost can also affect cumulative recognition. A technically successful project can therefore have disappointing financial results if engineering work is underestimated or customer requirements change. The model allows better margins over time, but the next evidence should include both commercial progress and reliable cost control. Stronger reporting improves confidence in inputs; stronger cash economics improves the investment value.
| Quality item | Treatment |
|---|---|
| Existing option and warrant claims | Separate conservative ownership allocation |
| Future compensation | Economic expense in forecast costs |
| Private investment gain | Not recurring operating profit |
| Control weaknesses | Remain unresolved; no cured-controls claim |
| Q2 comparison | Corrected filed figures used |
At September 30, cash and equivalents were $51.890 million, current available-for-sale securities $426.825 million and non-current securities $81.307 million. The total is $560.022 million. These securities are not all bank cash and carry market-value and duration risk. The 10-Q states that approximately $28.3 million was collected from employees and former employees for related tax withholding and is unavailable to fund operations. Removing that amount leaves $531.722 million before subsequent burn, claims and the operating reserve.
We assume $30 million of total fourth-quarter cash burn, with half already elapsed by the November valuation and half remaining. This is a modeling approximation, not a newly reported bank balance. Small conditional acquisition cash obligations receive separate reserves of $0.2 million and $1.5 million. Estimated cash after those current adjustments is $515.022 million. The model then reserves $60 million for operating liquidity. Payroll withholding is excluded from both the available-cash bridge and the opening operating-capital calculation so its future remittance is not charged a second time.
The latest quarter used $16.3 million of operating cash and $5.2 million for capital expenditure. Annualizing that combined use produces $86 million, against which available September funds represent approximately 6.2 years. This is an independent static cash-use illustration, not a runway forecast. Future development and deployment spending can increase, and historical cash flows include noncash compensation and working-capital timing. We do not add the entire September withholding liability to quarterly or nine-month cash use as if a balance were automatically a flow.
The base forecast requires about $58.0 million of gross future equity in 2032–2033 to maintain the cash floor. The faster bull requires $181.7 million because deployment spending rises ahead of cash generation. The neutral financing assumption prices new shares at the model’s fair value at each round and charges 5% issuance costs. This assumes access to capital on fair terms, not a commitment. New money receives matching ownership, so it does not create a present-value windfall. Below-fair-value financing or an inability to raise funds would worsen the outcomes.
| Metric | Value |
|---|---|
| Cash and securities | 560.02 |
| Withholding obligation | 28.30 |
| After withholding | 531.72 |
| Year | Gross capital | Issue price assumption | New shares |
|---|---|---|---|
| 2032 | $39.99m | $3.09 | 12.951m |
| 2033 | $18.01m | $3.58 | 5.035m |
The main model discounts enterprise cash after economic compensation, tax and reinvestment at 16%. It adds adjusted financial assets, excludes required operating cash and accounts for the remaining near-term cash use and future financing fees. No funded debt or currently outstanding preferred stock is reported. Historical preferred shares converted in the completed business combination and are already represented in the current common count. The model does not deduct future operating burn a second time after it has been included in discounted cash flow.
The November 12 common count is 226.247 million. We add 0.851 million restricted units, 25.796 million options and 10.412 million warrants as a deliberately conservative, zero-exercise-proceeds common-equivalent allocation. This is not a prediction that every award vests or every warrant exercises. Actual options have a $3.34 weighted-average strike; 17.596 million are exercisable at a $1.18 weighted-average strike. Public warrants have an $11.50 strike and expire on February 13, 2031, subject to earlier redemption or liquidation. Private warrants have different expiration terms.
The allocation also includes a conservative 0.512 million potential common-equivalent proxy for an old preferred-share contingent entitlement. Its actual common conversion is not verified, the entitlement is conditional, and management does not expect the contingencies to become probable. Legally issued restricted common shares and vested founder shares are already inside the spot common count and are not added again. Morton’s $3.3 million contingent liability largely represents those issued restricted shares; the model does not subtract the whole liability and count the same ownership twice. The total allocated proxy is 263.818 million shares.
The November 12 spot common count exceeds the September 30 count by 210,915 shares. Subsequent option exercises and award-settlement details have not been reconciled in this model, and we do not assert that they explain all of the increase. Because the conservative ownership proxy adds the full September award counts to the later spot count without exercise proceeds, it may overlap some of that increase. This dated-count limitation can modestly understate per-share value and should be refined when the detailed share roll-forward is available.
Base operating enterprise value is only $35.9 million. Negative explicit cash-flow value of $236.1 million offsets most of the $272.0 million terminal contribution. Adjusted financial assets consequently provide most present equity value. This does not make cash a guaranteed floor: the ongoing business consumes it, and the operating reserve is required. A 25% larger computing path raises present value to about $2.03; combining that with five additional gross-margin points gives about $2.50. The scenario is highly sensitive to commercialization timing, investment and mature economics, not just the starting share count.
| Metric | Value |
|---|---|
| Bear | 0.50 |
| Base | 1.84 |
| Bull | 4.06 |
| Computing scale | Gross-margin shift | Present value |
|---|---|---|
| 75% | −5% | $1.29 |
| 75% | +0% | $1.65 |
| 75% | +5% | $2.01 |
| 100% | −5% | $1.42 |
| 100% | +0% | $1.84 |
| 100% | +5% | $2.25 |
| 125% | −5% | $1.55 |
| 125% | +0% | $2.03 |
| 125% | +5% | $2.50 |
The retained Stock Analysis page shows a $19.57 average twelve-month target from seven analysts, with a $12 low and a $25 high. The page was last updated November 3, before these earnings, and attributes consensus information to S&P Global Market Intelligence. It is dated context rather than a confirmed post-results consensus. Our November 2027 base price is approximately $1.85, derived from the remaining business value and forecast cash at that date. We do not compare the twelve-month Street target with an undisclosed valuation clock.
An independent economic check uses Oxford Instruments’ November 10 interim results. The mature scientific-equipment company reported £201.1 million of revenue and £27.1 million of statutory operating profit, a 13.5% margin. Adjusted operating profit was £30.0 million, a 14.9% margin. These figures provide context for the economics of commercial scientific instruments. They are not a claim that Oxford and Infleqtion have the same products, software mix, accounting, lease treatment, geography or development stage. Quantum computing could ultimately support different margins.
Using that 13.5%–14.9% margin range, a 25% tax assumption and an author-selected 20-times after-tax operating earnings capitalization implies approximately $737 million–$814 million of already-mature annual revenue to support the quote under our conservative ownership and cash bridge. The twenty-times figure is an analytical assumption, not Oxford’s observed trading multiple. This is a scale test, not an independent per-share target. It highlights how different today’s revenue and development spending are from a mature, profitable technology-instrument franchise.
The main reverse calculation asks a different question: how much computing scale is needed within the full investment and timing model to reproduce the $8.01 quote? Holding the sensing path, margin rules, discount rate and terminal policy fixed requires roughly 9.34 times the base computing path. Total 2038 revenue approaches $6.94 billion, with about 514 annual system equivalents and proportionately greater access revenue. Research, equipment and operating capital increase as well. The source does not establish capacity for those units. Earlier success or different economics would change the solve.
| Metric | Value |
|---|---|
| 2026 guide floor | 45.10 |
| 14.9% margin hurdle | 737.29 |
| 13.5% margin hurdle | 813.75 |
| Metric | Value |
|---|---|
| Base 2038 revenue | 1,100.00 |
| Quote-implied revenue | 6,939.20 |
The business combination completed in February supplied $528.166 million of proceeds net of redemptions, with $518.868 million recorded after the stated equity issuance costs. That financing transformed the treasury and enabled a larger development program. It should not be mistaken for internally generated cash. The historical preferred-stock conversion and founder-share arrangements are already part of the current capital structure. A per-share analysis must begin with the security investors own today rather than carrying forward the old private-company share count.
The model assumes research and commercial spending grow with the opportunity. In the base, annual capital expenditure begins at $18 million and reaches $110 million in 2038, while owned-asset depreciation is 3% of revenue. Noncash operating capital is 15% of sales. The starting proxy is $1.809 million after separating payroll withholding and the equity-related contingent liability from operating accruals. This is an aggregate forecasting convention rather than a claim that each future balance-sheet caption will move mechanically with sales.
Operating lease liabilities were $16.912 million at September 30. A November facility amendment adds approximately $6.8 million of payments over the remaining term through August 2037 and was not yet recorded in the September balance sheet. Future rent is retained in operating costs, and only owned-asset depreciation is added back. We therefore do not also subtract lease liabilities as if those payments were absent from cash flow. Expansion capacity is not treated as free. The finite downside includes an assumed allowance for closure and lease-exit costs.
Future equity financing is priced at modeled fair value in the neutral case. This is deliberately different from assuming either costless funding or an arbitrary large discount that predetermines a low valuation. Base rounds add approximately 18.0 million shares to the allocated opening proxy, with modeled issue prices around $3.09 and $3.58 in 2032 and 2033. These are outputs of the remaining-value calculation, not quoted financing terms. If commercial milestones disappoint when capital is needed, fair-value access itself may be an optimistic assumption and the downside must be reconsidered.
| Year | Research | SG&A | Capex | Operating capital | FCFF |
|---|---|---|---|---|---|
| 2027 | $50.0m | $45.0m | $18.0m | $9.6m | $-99.3m |
| 2028 | $55.0m | $48.0m | $22.0m | $13.0m | $-95.4m |
| 2029 | $60.0m | $52.0m | $28.0m | $17.8m | $-93.6m |
| 2030 | $65.0m | $55.0m | $35.0m | $25.1m | $-82.7m |
| 2031 | $70.0m | $60.0m | $45.0m | $34.9m | $-64.8m |
| 2032 | $75.0m | $70.0m | $55.0m | $47.9m | $-42.1m |
| 2033 | $85.0m | $80.0m | $65.0m | $63.6m | $-17.1m |
| 2034 | $100.0m | $90.0m | $75.0m | $81.3m | $10.1m |
| 2035 | $115.0m | $105.0m | $85.0m | $101.0m | $37.6m |
| 2036 | $130.0m | $120.0m | $95.0m | $122.5m | $72.4m |
| 2037 | $145.0m | $135.0m | $105.0m | $144.2m | $109.1m |
| 2038 | $160.0m | $150.0m | $110.0m | $165.0m | $149.7m |
The strongest bull connects technical performance with repeat commercial sales. Sensing products become useful deployed instruments, computing installations establish credibility, and customers pay for valuable access and workloads. The bull reaches $2.604 billion of revenue in 2038, including 138 annual computing system equivalents. It allows higher gross margins and a larger access business, while paying for substantially more research and equipment. Its present value of $4.06 reflects that path and the conservative ownership allocation. A larger or earlier commercial breakthrough could create a result beyond this scenario.
The bear assumes technical progress does not translate into sufficient demand on the expected schedule. Government development work remains limited, commercial workloads fail to justify spending, or other architectures win the profitable applications. Revenue rises only to $64 million in 2030 despite cost reductions. We then model an orderly wind-down rather than indefinite negative cash flow. Remaining cash, a portion of noncash operating assets and equipment, and the separately valued private investment are reduced by $25 million of closure costs before the modeled ownership claims receive value.
The resulting illustrative 2030 receipt is about $0.93 per allocated share, worth approximately $0.50 at the valuation date. It is not a liquidation appraisal or guaranteed floor. Equipment recovery, private-investment liquidity, contract losses, legal claims and lease obligations can differ from the assumptions. A management team that continues to spend longer before changing course could leave less cash. Conversely, strategic technology value might produce recovery beyond our asset assumptions. The scenario makes the failure mechanism explicit without claiming that every possible failure follows this timetable.
Technical risk is represented through deployment and access paths; commercial risk through price, margin and customer conversion; investment risk through research, equipment and operating capital; financing risk through cash needs and ownership assumptions. Accounting and control weaknesses limit confidence in the inputs and identify verification priorities. We do not apply another blanket discount to every line for the same concerns. The 30/50/20 weights are subjective judgments, not calibrated odds. Neither the scenario range nor a sensitivity table replaces new evidence that customers can obtain useful performance at profitable economics.
| Metric | Value |
|---|---|
| Bear | 0.93 |
| Base | 2.34 |
| Bull | 6.52 |
The immediate financial test is the fourth-quarter delivery needed to reach at least $45.1 million of annual revenue. The implied $12.506 million minimum should be assessed alongside gross profit, project-cost estimates, collections and operating cash. More revenue with unfavorable contract economics would not establish the improvement the valuation needs. The $36.1 million of scheduled 2027 obligations is a useful baseline for the following year, but new work and profitable execution remain necessary for our modeled $64 million of total 2027 revenue.
The technical roadmap points to 100 logical qubits in 2028. Investors should seek evidence of useful workloads and customer applications, not merely a larger headline count. Deployments in Japan and the United Kingdom and collaborations in computing, networking and error correction can support that effort. Their investment significance depends on how they improve performance, adoption and revenue quality. A partnership announcement is not automatically a purchase commitment, and a scientific demonstration is not automatically a profitable recurring business.
The next filings should also clarify tax-withholding remittance, cash commitments, award settlements and control remediation. The $28.3 million collected for taxes should not remain part of any freely spendable treasury claim. Current system and accounting weaknesses should be reassessed from the actual control disclosures rather than presumed resolved. New lease commitments, equipment purchases and research hiring need to be incorporated into the cash forecast. Faster progress is most valuable when it improves revenue and margins without requiring a matching increase in capital consumption.
The December 2030 base price of $2.34 revalues the remaining operating cash flows and uses forecast cash and shares at that date. It implies approximately −25.8% annualized from the dated quote, assuming no dividends. The bull price is approximately $6.52, also below $8.01. These are conditional model outcomes, not claims that the market will follow a timetable. We would improve the investment call if commercially useful performance became repeatable sales faster than modeled, with better cash margins and investment efficiency. Until then, the 18% required return is not supported by the modeled cases.
| Metric | Value |
|---|---|
| Base annualized return | −25.78 |
| Bull annualized return | −4.88 |
| Required return | 18.00 |
Reported financial inputs come from the current September 30 Form 10-Q and the November 16 issuer release. The sequential comparison comes from the corrected June 30 filing and the August amendment explaining the changes to preliminary results. Technical milestones, current guidance and named awards are attributed to the company rather than independently verified commercial-performance claims. The source record supports their reported status, while the investment analysis distinguishes technical progress from the adoption, margins and cash needed to create shareholder value.
The quote is a retained Yahoo Finance after-hours observation. Analyst context is the November 3 Stock Analysis snapshot, attributed there to S&P Global Market Intelligence, with individual analyst data identified as coming from TipRanks. The independent instrument-economics check uses Oxford Instruments’ November 10 interim results. Its reported and adjusted margins are shown separately, and the 20-times earnings capitalization is our assumption. No current matched trading multiple, guaranteed quantum margin or new post-earnings analyst consensus is implied.
Tables show the forecast revenue engines, operating costs, investment, financing, ownership and valuation outcomes. Amounts are generally U.S. dollars in millions, except explicitly stated sterling, percentages, units, shares and per-share values. Forecast years end in December. Display rounding can create small differences from full-precision calculations. The fair-value financing assumption is neutral about transfers between old and new shareholders, while issuance costs are charged once. Actual financing at a discount, different award exercise proceeds or changes in contingent consideration would require a revised ownership bridge.
The allocated existing-share proxy is conservative and deliberately simpler than valuing every option and warrant separately. It does not assert that expired instruments remain legally outstanding, nor that conditional preferred-share entitlements are verified common shares. The private investment is illiquid, the cash forecast assumes no future portfolio yield, and annual cash-floor checks do not guarantee daily liquidity. The distant terminal contribution is large relative to net operating value because development cash outflows come first. These limitations are part of the conclusion: technical promise is visible, but precise long-term stock value remains highly uncertain.
| Discount rate | Terminal growth | Base present value |
|---|---|---|
| 14% | 1.5% | $2.24 |
| 14% | 2.5% | $2.30 |
| 14% | 3.5% | $2.36 |
| 16% | 1.5% | $1.81 |
| 16% | 2.5% | $1.84 |
| 16% | 3.5% | $1.87 |
| 18% | 1.5% | $1.54 |
| 18% | 2.5% | $1.55 |
| 18% | 3.5% | $1.56 |
Current Q3 filing · Corrected Q2 filing · Prior-results amendment · Q3 issuer release · Oxford Instruments interim results · Dated analyst context · Dated quote chart